Annual EBITDA
-$282.37M$189.67M+40.18%
Summary
- Current Value
- As of today, ASND annual EBITDA is -$282.37M, up +40.18% on
- Historical Performance
- ASND annual EBITDA is up +45.26% over the past 3 years, and down -14.66% over the past 5 years
- All-Time High Comparison
- ASND annual EBITDA is currently -3841.94% below its historical high of $7.55M set on
- 3-Year Low Comparison
- ASND annual EBITDA is +50.60% above its 3-year low of -$571.58M reached on an earlier date
- Sector Comparison
- ASND annual EBITDA is higher than 4.33% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$282.37M | +40.2% | +45.3% | -14.7% | – | |
| Quarterly EBITDA | $17.55M | +117.3% | +112.5% | +119.6% | – | |
| TTM EBITDA | -$137.34M | +57.4% | +75.0% | +57.9% | – | |
| Price | $215.04 | +59.4% | +86.9% | +36.2% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $393.35M | +36.4% | +4178.5% | +2527.6% | – | |
| Annual EPS | -$7.06 | +23.6% | +14.7% | -34.6% | – | |
| Annual EBIT | -$301.54M | +38.8% | +43.5% | -18.8% | – | |
| Annual Net Income | -$408.97M | +21.4% | +9.8% | -67.6% | – |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$282.37M | at high | |
| 5Y | -$282.37M | at high | |
| All | $7.55M | -3841.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$571.58M | N/A | +50.6% |
| 5Y | -$571.58M | +50.6% | |
| All | -$571.58M | +50.6% |
EBITDA History
FAQ
What is the current annual EBITDA of ASND?
As of today, ASND annual EBITDA is -$282.37M
What is 1-year change in ASND annual EBITDA?
ASND annual EBITDA is up +40.18% year-over-year
What is 3-year change in ASND annual EBITDA?
ASND annual EBITDA is up +45.26% over the past 3 years
How far is ASND annual EBITDA from its all-time high?
ASND annual EBITDA is currently -3841.94% below its historical high of $7.55M set on December 31, 2013
How does ASND annual EBITDA rank versus sector peers?
ASND annual EBITDA is higher than 4.33% of companies in Healthcare sector
When is ASND next annual earnings release?
The next annual earnings release for ASND is on
Quarterly EBITDA
$17.55M$72.72M+131.80%
Summary
- Current Value
- As of today, ASND quarterly EBITDA is $17.55M, up +131.80% on
- Historical Performance
- ASND quarterly EBITDA is up +117.29% year-over-year, and up +112.45% over the past 3 years
- All-Time High Comparison
- ASND quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ASND quarterly EBITDA is +111.75% above its 3-year low of -$149.29M reached on
- Sector Comparison
- ASND quarterly EBITDA is higher than 80.83% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $17.55M | +131.8% | +117.3% | +112.5% | +119.6% | |
| Annual EBITDA | -$282.37M | – | +40.2% | +45.3% | -14.7% | |
| TTM EBITDA | -$137.34M | +46.4% | +57.4% | +75.0% | +57.9% | |
| Price | $215.04 | +3.8% | +59.4% | +86.9% | +36.2% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $249.64M | +39.3% | +292.9% | +1521.8% | +7647.1% | |
| Quarterly EPS | -$1.17 | -60.9% | +38.1% | +61.5% | +56.5% | |
| Quarterly EBIT | $12.85M | +121.4% | +112.1% | +108.8% | +114.0% | |
| Quarterly Net Income | -$71.27M | -61.7% | +34.6% | +58.1% | +49.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $17.55M | at high | |
| 3Y | $17.55M | at high | |
| 5Y | $17.55M | at high | |
| All | $17.55M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$104.90M | +116.7% | |
| 3Y | -$149.29M | +111.8% | |
| 5Y | -$149.29M | +111.8% | |
| All | -$149.29M | +111.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ASND?
As of today, ASND quarterly EBITDA is $17.55M
What is ASND quarterly EBITDA most recent change?
ASND quarterly EBITDA was up +131.80% on September 30, 2025
What is 1-year change in ASND quarterly EBITDA?
ASND quarterly EBITDA is up +117.29% year-over-year
How far is ASND quarterly EBITDA from its all-time high?
ASND quarterly EBITDA is currently at its all-time high
How does ASND quarterly EBITDA rank versus sector peers?
ASND quarterly EBITDA is higher than 80.83% of companies in Healthcare sector
When is ASND next earnings release?
The next earnings release for ASND is on
TTM EBITDA
-$137.34M$119.02M+46.43%
Summary
- Current Value
- As of today, ASND TTM EBITDA is -$137.34M, up +46.43% on
- Historical Performance
- ASND TTM EBITDA is up +57.44% year-over-year, and up +75.02% over the past 3 years
- All-Time High Comparison
- ASND TTM EBITDA is currently -2490.21% below its historical high of $5.75M set on
- 3-Year Low Comparison
- ASND TTM EBITDA is +76.49% above its 3-year low of -$584.18M reached on
- Sector Comparison
- ASND TTM EBITDA is higher than 12.21% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$137.34M | +46.4% | +57.4% | +75.0% | +57.9% | |
| Annual EBITDA | -$282.37M | – | +40.2% | +45.3% | -14.7% | |
| Quarterly EBITDA | $17.55M | +131.8% | +117.3% | +112.5% | +119.6% | |
| Price | $215.04 | +3.8% | +59.4% | +86.9% | +36.2% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $720.68M | +34.8% | +103.3% | +1947.0% | +7084.8% | |
| TTM EPS | -$4.25 | +14.5% | +47.5% | +53.9% | +48.0% | |
| TTM EBIT | -$156.48M | +43.2% | +54.3% | +72.5% | +53.4% | |
| TTM Net Income | -$255.97M | +12.8% | +44.6% | +50.6% | +36.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$137.34M | at high | |
| 3Y | -$137.34M | at high | |
| 5Y | -$137.34M | at high | |
| All | $5.75M | -2490.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$339.92M | +59.6% | |
| 3Y | -$584.18M | +76.5% | |
| 5Y | -$584.18M | +76.5% | |
| All | -$584.18M | +76.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ASND?
As of today, ASND TTM EBITDA is -$137.34M
What is ASND TTM EBITDA most recent change?
ASND TTM EBITDA was up +46.43% on September 30, 2025
What is 1-year change in ASND TTM EBITDA?
ASND TTM EBITDA is up +57.44% year-over-year
How far is ASND TTM EBITDA from its all-time high?
ASND TTM EBITDA is currently -2490.21% below its historical high of $5.75M set on December 31, 2013
How does ASND TTM EBITDA rank versus sector peers?
ASND TTM EBITDA is higher than 12.21% of companies in Healthcare sector
When is ASND next earnings release?
The next earnings release for ASND is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ASND Official Website ascendispharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1612042/000119312525277622/0001193125-25-277622-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1612042/000095017025018852/0000950170-25-018852-index.htm
- ASND Profile on Yahoo Finance finance.yahoo.com/quote/ASND
- ASND Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/asnd